Citadel Advisors »

Mbx Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mbx Biosciences shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 136k 25.98

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
NVP Associates
RA Capital Management
T. Rowe Price Associates
Driehaus Capital Management
Woodline Partners
Franklin Resources
Alyeska Investment Group
Platinum Investment Mangement
Citadel Advisors
Stempoint Capital
Monashee Investment Management
TD Asset Management

View all funds holding Mbx Biosciences